Biogen may want to listen carefully to what patients are saying about Tecfidera and it’s DTC ads. One person remarked that Biogen raised the price 6% to hit sales numbers while others within the MS community are throwing darts at the ads.
I have been monitoring MS patients on social media for almost a year now and found that they are a tight integrated community who share a lot of information and are keen on new drugs in development. From the social media, it’s easy to see why this Biogen drug is in trouble, so I would then ask the question “what makes Biogen think that a DTC ad is going to change the current issues?”. Does Biogen really believe people are not going to do their homework before deciding to ask for this drug?